High mannose-specific lectin (KAA-2) from the red alga Kappaphycus alvarezii potently inhibits influenza virus infection in a strain-independent manner

Biochemical and Biophysical Research Communications

Volumn 405, Issue 2, 2011, Pages 291-296

  Sato, Yuichiro ^a   Morimoto, Kinjiro ^a   Hirayama, Makoto ^b   Hori, Kanji ^b  

^a YASUDA WOMEN'S UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Anti influenza activity; High mannose type N glycan; Lectin; Red algae

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; HEMAGGLUTININ; KAA 2; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST CELL; IMMUNOFLUORESCENCE MICROSCOPY; INFLUENZA; INFLUENZA VIRUS A H1N1; KAPPAPHYCUS ALVAREZII; NONHUMAN; PRIORITY JOURNAL; RED ALGA; VIRUS ENTRY; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHICK EMBRYO; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LECTINS; MANNOSE-BINDING LECTINS; RHODOPHYTA;

ALGAE; EUCHEUMA SERRA; KAPPAPHYCUS ALVAREZII; ORTHOMYXOVIRIDAE; RHODOPHYTA;

EID: 79651472458     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.031     Document Type: Article

References (25)

1. Ziółkowska N.E., Wlodawer A. Structural studies of algal lectins with anti-HIV activity. Acta Biochim. Pol. 2006, 53:617-626.
2. Balzarini J. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat. Rev. Microbiol. 2007, 5:583-597.
3. Boyd M.R., Gustafson K.R., Mcmahon J.B., Shoemaker R.H., O'Keefe B.R., Mori T., Gulakowski R.J., Wu L., Rivera M.I., Laurencot C.M., Currens M.J., Cardellina J.H., Buckheit R.W., Nara P.L., Pannell L.K., Sowder R.C., Henderson L.E. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential application to microbicide development. Antimicrob. Agents Chemother. 1997, 41:1521-1530.
4. Bewley C.A., Gustafson K.R., Boyd M.R., Covell D.G., Bax A., Clore G.M., Gronenborn A.M. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat. Struct. Biol. 1998, 5:571-578.
5. Bokesch H.R., O'Keefe B.R., McKee T.C., Pannell L.K., Patterson M.L., Gardella R.S., Sowder R.C., Turpin J., Watson K., Buckheit R.W., Boyd M.R. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Biochemistry 2003, 42:2578-2584.
6. Yamaguchi M., Ogawa T., Muramoto K., Kamio Y., Jimbo M., Kamiya H. Isolation and characterization of a mannan-binding lectin from the freshwater cyanobacterium (blue-green algae) Microcystis viridis. Biochem. Biophys. Res. Commun. 1999, 265:703-708.
7. Huskens D., Férir G., Vermeire K., Kehr J.C., Balzarini J., Dittmann E., Schols D. Microvirin, a novel alpha(1,2)-mannose specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile. J. Biol. Chem. 2010, 285:24845-24854.
8. Sato Y., Okuyama S., Hori K. Primary structure and carbohydrate-binding specificity of a potent anti-HIV lectin isolated from the filamentous cyanobacterium, Oscillatoria agardhii. J. Biol. Chem. 2007, 282:11021-11029.
9. Mori T., O'Keefe B.R., Sowder R.C., Bringans S., Gardella R.S., Berg S., Cochran P., Turpin J.A., Buckheit R.W., McMahon J.B., Boyd M.R. Isolation and characterization of Griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 2005, 280:9345-9353.
10. Hori K., Sato Y., Fujiwara Y., Ito K., Iwamoto Y., Makino H., Kawakubo A. Strict specificity for high mannose-type N-glycans and primary structure of a red alga Eucheuma serra lectin. Glycobiology 2007, 17:479-491.
11. Li Y., Cleveland B., Klots I., Travis B., Richardson B.A., Anderson D., Montefiori D., Polacino P., Hu S. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. J. Virol. 2008, 82:638-651.
12. Duvet S., Cocquerel L., Pillez A., Cacan R., Verbert A., Moradpour D., Wychowski C., Dubuisson J. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J. Biol. Chem. 1998, 273:32088-32095.
13. Ritchie G., Harvey D.J., Feldmann F., Stroeher U., Feldmann H., Royle L., Dwek R.A., Rudd P.M. Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology 2010, 399:257-269.
14. Helle F., Wychowski C., Vu-Dac N., Gustafson K.R., Voisset C., Dubisson J. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J. Biol. Chem. 2006, 281:25177-25183.
15. O'Keefe B.R., Smee D.F., Turpin J.A., Saucedo C.J., Gustafson K.R., Mori T., Blakeslee D., Buckheit R., Boyd M.R. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob. Agents Chemother. 2003, 47:2518-2525.
16. Barrientos L.G., O'Keefe B.R., Bray M., Sanchez A., Gronenborn A.M., Boyd M.R. Cyanovirin-N binds to the viral surface glycoprotein, gp1, 2 and inhibits infectivity of Ebola virus. Antiviral Res. 2003, 58:47-56.
17. O'Keefe B.R., Giomarelli B., Barnard D.L., Shenoy S.R., Chan P.K., McMahon J.B., Palmer K.E., Barnett B.W., Meyerholz D.K., Wohlford-Lenane C.L., McCray P.B. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J. Virol. 2010, 84:2511-2521.
18. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459:931-939.
19. Octaviani C.P., Ozawa M., Yamada S., Goto H., Kawaoka Y. High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J. Virol. 2010, 84:10918-10922.
20. Kawakubo A., Makino H., Ohnishi J., Hirohara H., Hori K. Occurrence of highly yielded lectins homologous within the genus Eucheuma. J. Appl. Phycol. 1999, 11:149-156.
21. Job E.R., Deng Y., Tate M.D., Bottazzi B., Crouch E.C., Dean M.M., Mantovani A., Brooks A.G., Reading P.C. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 2010, 185:4284-4291.
22. Mir-Shekari S.Y., Ashford D.A., Harvey D.J., Dwek R.A., Schulze I.T. The glycosylation of the influenza A virus hemagglutinin by mammalian cells. J. Biol. Chem. 1997, 272:4027-4036.
23. Zhang M., Gaschen B., Blay W., Foley B., Haigwood N., Kuiken C., Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004, 14:1229-1246.
24. Hartshorn K.L., Webby R., White M.R., Tecle T., Pan C., Boucher S., Moreland R.J., Crouch E.C., Scheule R.K. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 2008, 9:1-12.
25. Fukuda Y., Sugahara T., Ueno M., Fukuta Y., Ochi Y., Akiyama K., Miyazaki T., Masuda S., Kawakubo A., Kato K. The anti-tumor effect of Eucheuma serra agglutinin on colon cancer cells in vitro and in vivo. Anticancer Drugs 2006, 17:943-947.